| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 12.6 | 14.4 | 14.6 |
| Other income | 0.0 | 0.0 | 0.3 |
| Total income | 12.6 | 14.4 | 14.9 |
| Profit before exceptional items & tax | 2.7 | 4.3 | 3.5 |
| Profit before tax | 2.7 | 4.3 | 3.5 |
| Net profit | 2.0 | 3.2 | 1.5 |
| Operating margin | 21.4% | 29.9% | 23.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +33.30% |
|---|---|
| Net profit, quarter on quarter | -37.50% |
| Revenue, year on year | -13.70% |
Source
Read the filing ↗
BSE results filing, BSE: 544629. Figures extracted from the filing.
Ravelcare Ltd: key numbers
- Share price
- ₹99.00
- Market cap
- ₹67.90 Cr
- Revenue (annual)
- ₹26.95 Cr
- Net profit (annual)
- ₹5.15 Cr
- P/E (TTM)
- 13.2×Sector 43.4×
- Promoter holding
- 72.94%
- FII holding
- 2.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ravelcare Ltd
All →
15:10 IST
BSE
Annual General Meeting
Ravelcare Annual General Meeting
Ravelcare Ltd submitted the proceedings of its 8th AGM held on September 23, 2026. Items covered adoption of audited FY26 financials and re-appointment of the MD, WTD, and a retiring director.